Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex-differences in [68Ga]Ga-DOTANOC biodistribution.
Leisser A, Lukic K, Nejabat M, Wadsak W, Mitterhauser M, Mayerhöfer M, Karnaikas G, Raderer M, Hacker M, Haug AR. Leisser A, et al. Among authors: raderer m. Nucl Med Biol. 2019 Sep-Oct;76-77:15-20. doi: 10.1016/j.nucmedbio.2019.08.005. Epub 2019 Aug 28. Nucl Med Biol. 2019. PMID: 31654811
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
Virgolini I, Angelberger P, Li S, Yang Q, Kurtaran A, Raderer M, Neuhold N, Kaserer K, Leimer M, Peck-Radosavljevic M, Scheithauer W, Niederle B, Eichler HG, Valent P. Virgolini I, et al. Among authors: raderer m. Eur J Nucl Med. 1996 Oct;23(10):1388-99. doi: 10.1007/BF01367597. Eur J Nucl Med. 1996. PMID: 8781146
Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
Mayerhoefer ME, Giraudo C, Senn D, Hartenbach M, Weber M, Rausch I, Kiesewetter B, Herold CJ, Hacker M, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M. Mayerhoefer ME, et al. Among authors: raderer m. Clin Nucl Med. 2016 Feb;41(2):101-5. doi: 10.1097/RLU.0000000000001005. Clin Nucl Med. 2016. PMID: 26402137 Free PMC article.
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Mayerhoefer ME, Karanikas G, Kletter K, Kiesewetter B, Weber M, Rausch I, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M. Mayerhoefer ME, et al. Among authors: raderer m. Clin Nucl Med. 2016 Nov;41(11):837-843. doi: 10.1097/RLU.0000000000001395. Clin Nucl Med. 2016. PMID: 27648705
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.
Mayerhoefer ME, Raderer M, Jaeger U, Staber P, Kiesewetter B, Senn D, Gallagher FA, Brindle K, Porpaczy E, Weber M, Berzaczy D, Simonitsch-Klupp I, Sillaber C, Skrabs C, Haug A. Mayerhoefer ME, et al. Among authors: raderer m. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):931-940. doi: 10.1007/s00259-018-3937-z. Epub 2018 Feb 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29480328 Free PMC article.
417 results